相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering
Olaf Oberschmidt et al.
HUMAN GENE THERAPY METHODS (2019)
NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing
Isabel Prager et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
Rafijul Bari et al.
FRONTIERS IN IMMUNOLOGY (2019)
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Stephan Kloess et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
May Daher et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
Weili Sun et al.
LEUKEMIA (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome
Anett Pfeiffer et al.
EMBO MOLECULAR MEDICINE (2018)
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
Sandro Matosevic
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells
Stephan Kloss et al.
HUMAN GENE THERAPY (2017)
Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21
Maria A. Streltsova et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
Markus Granzin et al.
FRONTIERS IN IMMUNOLOGY (2017)
Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
Federico Simonetta et al.
FRONTIERS IN IMMUNOLOGY (2017)
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
Claudia Piovan et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles
Louic S. Vermeer et al.
ACTA BIOMATERIALIA (2017)
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation
Stefan O. Ciurea et al.
BLOOD (2017)
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma
Sarah Oelsner et al.
CYTOTHERAPY (2017)
Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells
Saliha Majdoul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors
Julia D. Suerth et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival
Sarah Oelsner et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Utilizing chimeric antigen receptors to direct natural killer cell activity
David L. Hermanson et al.
FRONTIERS IN IMMUNOLOGY (2015)
Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
Inpyo Choi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs
Anais Girard-Gagnepain et al.
BLOOD (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
M. Stern et al.
BONE MARROW TRANSPLANTATION (2013)
Alpharetroviral Vector-mediated Gene Therapy for X-CGD: Functional Correction and Lack of Aberrant Splicing
Kerstin B. Kaufmann et al.
MOLECULAR THERAPY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Vectofusin-1, a New Viral Entry Enhancer, Strongly Promotes Lentiviral Transduction of Human Hematopoietic Stem Cells
David Fenard et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
New prospects on the NKG2D/NKG2DL system for oncology
Evelyn Ullrich et al.
ONCOIMMUNOLOGY (2013)
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
Nicola Goekbuget et al.
BLOOD (2012)
Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens
Laurent Boissel et al.
LEUKEMIA & LYMPHOMA (2012)
Alpharetroviral Self-inactivating Vectors: Long-term Transgene Expression in Murine Hematopoietic Cells and Low Genotoxicity
Julia D. Suerth et al.
MOLECULAR THERAPY (2012)
Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma
Keichiro Mihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design
Julia D. Suerth et al.
JOURNAL OF VIROLOGY (2010)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Natural killer cell-directed therapies: moving from unexpected results to successful strategies
Magali Terme et al.
NATURE IMMUNOLOGY (2008)
Serial Killing of Tumor Cells by Human Natural Killer Cells - Enhancement by Therapeutic Antibodies
Rauf Bhat et al.
PLOS ONE (2007)
Activation and self-tolerance of natural killer cells
Stephan Gasser et al.
IMMUNOLOGICAL REVIEWS (2006)
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells
A Schambach et al.
MOLECULAR THERAPY (2006)
The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes
A. James Mason et al.
FASEB JOURNAL (2006)
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
C Imai et al.
BLOOD (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules:: implications for tumor immune escape
I Algarra et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates
V Sandrin et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92
G Maki et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus
M Marin et al.
JOURNAL OF VIROLOGY (2000)
分享论文
